Advertisement

Critical Care Management of Refractory Status Epilepticus

  • J. Claassen
  • L. J. Hirsch
  • S. A. Mayer

Abstract

Status epilepticus is defined as continuous or repetitive seizure activity persisting for at least 30 minutes without recovery of consciousness between attacks. Though differing to some degree, most authors define refractory status epilepticus as generalized status epilepticus that continues clinically or electrographically despite first and second line therapy. Definitions differ primarily regarding the required number of failed anticonvulsant drugs (two [1–5] or three [6–9]), and whether a minimum duration of persistent seizure activity is required (ranging from none [1, 5, 7–9] to one [3] or two [2, 4] hours). Status epilepticus can be classified according to clinical and electroencephalogram (EEG) findings (Fig. 1).

Keywords

Status Epilepticus Refractory Status Refractory Status Epilepticus Convulsive Status Epilepticus Nonconvulsive Status Epilepticus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jagoda A, Riggio S (1993) Refractory status epilepticus in adults. Ann Emerg Med 22: 1337–1348PubMedCrossRefGoogle Scholar
  2. 2.
    Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E, Skaar DJ (1998) Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 39: 18–26PubMedCrossRefGoogle Scholar
  3. 3.
    Hanley DF, Kross JF (1998) Use of midazolam in the treatment of refractory status epilepticus. Clin Ther 20: 1093–1105PubMedCrossRefGoogle Scholar
  4. 4.
    Prasad A, Worrall BB, Bertram EH, Bleck TP (2001) Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 42: 380–386PubMedCrossRefGoogle Scholar
  5. 5.
    Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA (2001) Continuous EEG monitoring and midazolam infusion for nonconvulsive refractory status epilepticus. Neurology 57: 1036–1042PubMedCrossRefGoogle Scholar
  6. 6.
    Bleck TP (1993) Advances in the management of refractory status epilepticus. Crit Care Med 21: 955–957PubMedCrossRefGoogle Scholar
  7. 7.
    Working Group on Status Epilepticus (1993) Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA 270: 854–859CrossRefGoogle Scholar
  8. 8.
    Cascino GD (1996) Generalized convulsive status epilepticus. Mayo Clin Proc 71: 787–792PubMedCrossRefGoogle Scholar
  9. 9.
    Lowenstein DH, Alldredge BK (1998) Status epilepticus. N Engl J Med 338: 970–976PubMedCrossRefGoogle Scholar
  10. 10.
    Shorvon S (1999) Status epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge University Press, CambridgeGoogle Scholar
  11. 11.
    Shorvon S (2000) Emergency treatment of epilepsy: acute seizures, serial seizure clusters and status epilepticus. In: Shorvon S (ed) Handbook of Epilepsy Treatment. Blackwell Science Ltd, Oxford, pp 173–194Google Scholar
  12. 12.
    Alldredge BK, Gelb AM, Isaacs SM, et al (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345: 631637Google Scholar
  13. 13.
    Kaplan PW (1999) Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 16: 341–352PubMedCrossRefGoogle Scholar
  14. 14.
    DeLorenzo RJ, Waterhouse EJ, Towne AR, et al (1998) Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 39: 833–840PubMedCrossRefGoogle Scholar
  15. 15.
    Kaplan PW (1996) Nonconvulsive status epilepticus in the emergency room. Epilepsia 37: 643–650PubMedCrossRefGoogle Scholar
  16. 16.
    Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM (1995) Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 45: 14991504Google Scholar
  17. 17.
    DeLorenzo RJ, Hauser WA, Towne AR, et al (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46: 1029–1035Google Scholar
  18. 18.
    Treiman DM, Meyers PD, Walton NY, et al (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 339: 792–798Google Scholar
  19. 19.
    Mayer SA, Claassen J, Lokin J, Fitzsimmons BF, Mendehlson F (2002) Predictors of refractory status epilepticus. Arch Neurol (in press)Google Scholar
  20. 20.
    Towne AR, Waterhouse EJ, Boggs JG, et al (2000) Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 54: 340–345PubMedCrossRefGoogle Scholar
  21. 21.
    Jordan KG (1992) Nonconvulsive seizures (NCS) and nonconvulsive status epilepticus (NCSE) detected by continuous monitoring in the Neuro ICU (NICU-CEEG). Neurology 42: 194 (Abst)Google Scholar
  22. 22.
    Claassen J, Hirsch LJ, Emerson RG, Mayer SA (2002) Treatment of refractory status epilepticus with pentobarbital, pmpofol, or midazolam: A systematic review. Epilepsia (in press)Google Scholar
  23. 23.
    Lowenstein DH, Alldredge BK (1993) Status epilepticus at an urban public hospital in the 1980s. Neurology 43: 483–488PubMedCrossRefGoogle Scholar
  24. 24.
    De Lorenzo RJ, Towne AR, Waterhouse EJ, Morton LD, Garnett LK, Ko D (2001) Refractory status epilepticus: clinical presentations, mortality, and risk factors. Epilepsia 42:144 (Abst)Google Scholar
  25. 25.
    Yaffe K, Lowenstein DH (1993) Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 43: 895–900PubMedCrossRefGoogle Scholar
  26. 26.
    Krishnamurthy KB, Drislane FW (1996) Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 37: 863–867PubMedCrossRefGoogle Scholar
  27. 27.
    Shneker BF, Fountain NB (2001) Epilepsy as chronic sequel of nonconvulsive status epilepticus. Epilepsia 42: 147 (Abst)Google Scholar
  28. 28.
    Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA (1997) Short-term mortality after a first episode of status epilepticus. Epilepsia 38: 1344–1349PubMedCrossRefGoogle Scholar
  29. 29.
    Waterhouse EJ, Garnett LK, Towne AR, et al (1999) Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 40: 752–758Google Scholar
  30. 30.
    Aminoff MJ, Simon RP (1980) Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 69: 657–666PubMedCrossRefGoogle Scholar
  31. 31.
    Towne AR, Pellock JM, Ko D, DeLorenzo RJ (1994) Determinants of mortality in status epilepticus. Epilepsia 35: 27–34PubMedCrossRefGoogle Scholar
  32. 32.
    Dennis LJ, Claassen J, Connolly ES, et al (2002) Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery (in press)Google Scholar
  33. 33.
    Jaitly R, Sgro JA, Towne AR, Ko D, De Lorenzo RJ (1997) Prognostic value of EEG monitoring after status epilepticus: a prospective adult study. J Clin Neurophys 14: 326–334CrossRefGoogle Scholar
  34. 34.
    Wijdicks EFM (1997) Status epilepticus. In: Wijdicks EFM (ed) The Clinical Practice of Critical Care Neurology. Lippincott-Raven, Philadelphia, pp 279–289Google Scholar
  35. 35.
    Claassen J, Lokin JK, Fitzsimmons BFM, Mendelsohn FA, Mayer SA (2002) Predictors of functional disability and mortality after status epilepticus. Neurology 58: 139–142PubMedCrossRefGoogle Scholar
  36. 36.
    Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B (1983) Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 249: 1452–1454PubMedCrossRefGoogle Scholar
  37. 37.
    Treiman DM, Walton NY, Collins JF, Point P (1999) Treatment of status epilepticus if first drug fails. Epilepsia 40: 243 (Abst)Google Scholar
  38. 38.
    Rashkin MC, Youngs C, Penovich P (1987) Pentobarbital treatment of refractory status epilepticus. Neurology 37: 500–503PubMedCrossRefGoogle Scholar
  39. 39.
    Lowenstein DH, Aminoff MJ, Simon RP (1988) Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology 38: 395–400PubMedCrossRefGoogle Scholar
  40. 40.
    Brown LA, Levin GM (1998) Role of propofol in refractory status epilepticus. Ann Pharmacotherapy 32: 1053–1059CrossRefGoogle Scholar
  41. 41.
    Walker MC, Smith SJM, Shorvon SD (1995) The intensive care treatment of convulsive status epilepticus in the UK. Anaesthesia 50: 130–135PubMedCrossRefGoogle Scholar
  42. 42.
    Sinha S, Naritoku DK (2000) Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 55: 722–724PubMedCrossRefGoogle Scholar
  43. 43.
    Treiman DM. Electroclinical features of status epilepticus (1995) J Clin Neurophys 12:343362Google Scholar
  44. 44.
    Garzon E, Fernandes RM, Sakamoto AC (2001) Serial EEG during human status epilepticus: evidence for PLED as an ictal pattern. Neurology 57: 1175–1183PubMedCrossRefGoogle Scholar
  45. 45.
    Nei M, Lee J-M, Shanker VL, Sperling MR (1999) The EEG and prognosis in status epilepticus. Epilepsia 40: 157–163PubMedCrossRefGoogle Scholar
  46. 46.
    Treiman DM, Walton NY, Kendrick C (1990) A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 5: 49–60PubMedCrossRefGoogle Scholar
  47. 47.
    Assai F, Papazyan JP, Slosman DO, Jallon P, Goerres GW (2001) SPECT in periodic lateralized epileptiform discharges (PLEDs): a form of partial status epilepticus? Seizure 10: 260265Google Scholar
  48. 48.
    Handforth A, Cheng JT, Mandelkern MA, Treiman DM (1994) Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus. Epilepsia 35: 876–81PubMedCrossRefGoogle Scholar
  49. 49.
    Pohlmann-Eden B, Hoch DB, Cochius JI, Chiappa KH (1996) Periodic lateralized epileptiform discharges - a critical review. J Clin Neurophysiol 13: 519–530PubMedCrossRefGoogle Scholar
  50. 50.
    Yaffe K, Ferriero D, Barkovich AJ, Rowley H (1995) Reversible MRI abnormalities following seizures. Neurology 45: 104–108PubMedCrossRefGoogle Scholar
  51. 51.
    Lazeyras F, Blanke O, Zimine I, Delavelle J, Perrig SH, Seeck M (2000) MRI, (1)H-MRS, and functional MRI during and after prolonged nonconvulsive seizure activity. Neurology 55: 1677–1682PubMedCrossRefGoogle Scholar
  52. 52.
    Chu K, Kang DW, Kim JY, Chang KH, Lee SK (2001) Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus. Arch Neurol 58: 993–998PubMedCrossRefGoogle Scholar
  53. 53.
    Lansberg MG, O’Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW (1999) MRI abnormalities associated with partial status epilepticus. Neurology 52: 1021–1027PubMedCrossRefGoogle Scholar
  54. 54.
    Petroff OA, Prichard JW, Behar KL, Alger JR, Shulman RG (1984) In vivo phosphorus nuclear magnetic resonance spectroscopy in status epilepticus. Ann Neurol 16: 169–177PubMedCrossRefGoogle Scholar
  55. 55.
    Beattie JL, Passaro EA, Kutluay E (2001) Ictal SPECT in nonconvulsive status epilepticus. Epilepsia 42: 70 (Abst)Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • J. Claassen
  • L. J. Hirsch
  • S. A. Mayer

There are no affiliations available

Personalised recommendations